Canada Edges Closer to National Pharmacare Program
Hotly awaited recommendations on implementing a national pharmacare program in Canada have been published. The report also suggests how to improve Canada’s pricing and reimbursement process.
You may also be interested in...
Big changes to Canada's pharmaceutical market could be afoot as the country starts to look at what a National Pharmacare program might look like. Moves to improve access to medicines could mean the demise of private drug plans, which would be bad news for companies.
Financial ties between companies and healthcare bodies distort the production and use of evidence, claims a paper co-authored by researchers, clinicians and decision makers, including a representative of Germany’s HTA body, IQWiG.